Boston Scientific Corporation (N:BSX)

Business Focus: Advanced Medical Equipment & Technology

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BSX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 19/20 Feb 19/20 Pierce David A Direct Ownership Common Stock S - Open market or private sale -1,511 $42.31
Feb 19/20 Feb 19/20 Ballinger Kevin J. Direct Ownership Common Stock S - Open market or private sale -1,757 $42.31
Feb 19/20 Feb 18/20 Thepaut Eric Francis Yves Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 29,867  
Feb 19/20 Feb 18/20 Thepaut Eric Francis Yves Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 8,005  
Feb 19/20 Feb 18/20 Sorenson John Bradley Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 17,699  
Feb 19/20 Feb 18/20 Sorenson John Bradley Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 4,743  
Feb 19/20 Feb 18/20 Scanlon Meghan Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 16,592  
Feb 19/20 Feb 18/20 Scanlon Meghan Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 4,447  
Feb 19/20 Feb 18/20 Ralls-Morrison Desiree Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,442  
Feb 19/20 Feb 18/20 Ralls-Morrison Desiree Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 6,819  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BSX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 20th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 19/20 Feb 18/20 Thepaut Eric Francis Yves Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 29,867  
Feb 19/20 Feb 18/20 Thepaut Eric Francis Yves Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 8,005  
Feb 19/20 Feb 18/20 Sorenson John Bradley Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 17,699  
Feb 19/20 Feb 18/20 Sorenson John Bradley Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 4,743  
Feb 19/20 Feb 18/20 Scanlon Meghan Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 16,592  
Feb 19/20 Feb 18/20 Scanlon Meghan Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 4,447  
Feb 19/20 Feb 18/20 Ralls-Morrison Desiree Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,442  
Feb 19/20 Feb 18/20 Ralls-Morrison Desiree Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 6,819  
Feb 19/20 Feb 18/20 Pierce David A Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 39,823  
Feb 19/20 Feb 18/20 Pierce David A Direct Ownership Deferred Stock Units A - Grant, award or other under Rule 16b-3(d) 10,673  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BSX

Competitors

Competitors with Recent Insider Filings
Edwards Lifesciences (N:EW)
Intuitive Surgical (OQ:ISRG)
Danaher (N:DHR)